by In2Pharma | Dec 10, 2019 | News
We are looking to expand our team with a Medical Affairs colleague who has the ambition and potential to grow in our organization. All projects within IN2Pharma are worked on in small teams of 2-5 people and for some projects, you also work on site at the clients’...
by In2Pharma | Nov 28, 2019 | News
Europe A new Commission Regulation has been published ((EU) 2019/1901) amending Regulation (EC) No 1881/2006 regarding maximum levels of citrinin in food supplements based on rice fermented with red yeast Monascus Purpureus. The maximum level of citrinin has been set...
by In2Pharma | Nov 22, 2019 | News
The Netherlands Starting from 26 May 2020 the ‘College ter Beoordeling van Geneesmiddelen (CBG)’ will be giving advice according to the new Medical Device Regulation (MDR, EU 2017/745). Starting from 1 December 2019, the CBG only handles requests for consultation...
by In2Pharma | Nov 22, 2019 | News
Belgium From January 2020 there is a new nomenclature applicable for manufacturers reporting an incident with a medical device to the FAMHP. The FAMHP advises manufacturers of medical devices to already change their internal codes to the new nomenclature codes. The...
by In2Pharma | Nov 6, 2019 | News
Belgium As a precaution, the European Medicines Agency (EMA) and European medicines authorities asked marketing authorisation holders in October 2019 to perform a risk assessment on the presence of nitrosamines. The Federal Agency for Medicines and Health Products...
